Across TCGA pan-cancer cohorts, TRIM60P5Y RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated TRIM60P5Y data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher TRIM60P5Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TRIM60P5Y expression acts as an unfavorable survival marker.
LUAD are the cancer types where TRIM60P5Y RNA most reproducibly stratifies survival.